Get started Log in

XERS — Xeris Biopharma Holdings News Story

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Market Cap
$1.84bn
Enterprise Value
$1.97bn
Revenue
$291.85m

Lundbeck expresses interest in buying Xeris, Bloomberg News reports

Xeris Biopharma Holdings

29/09/2026 18:02

Lundbeck expresses interest in buying Xeris, Bloomberg News reportsSept 29 (Reuters) - Danish drugmaker H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma XERS.O, Bloomberg News reported on Tuesday, citing people familiar with the matter.

 (Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
 ((Christy.Santhosh@thomsonreuters.com;))

Recent news on Xeris Biopharma Holdings

Brief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
14/10/2026 13:19
Deals of the day-Mergers and acquisitions
30/09/2026 10:45
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
29/09/2026 18:45
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
29/09/2026 18:43
Xeris Biopharma rises on report of Lundbeck takeover interest
29/09/2026 18:08